Funding round
Nimbus Therapeutics Growth
Reported as "Growth Equity"
Nimbus Therapeutics, which works in precision small molecule drug discovery in Boston, raised $125M in a Growth round announced on 12 Sep 2022, led by Bain Capital Life Sciences and SV Health Investors. 10 firms took part, with 1 individual investor. It is Nimbus Therapeutics' sixth venture round on record; the one before was a Growth in Jul 2021.
$125M
Amount raised
Not disclosed
Post-money valuation
10
Investors
2 leads
Valuation
What this round says about the price
Nimbus Therapeutics did not disclose a valuation in this round. It came 14 months after Nimbus Therapeutics' Growth. It is 22% of the $569M Nimbus Therapeutics has raised in the venture rounds on record. Nimbus Therapeutics raised again 12 months later: a Growth round of $210M in Sep 2023.
Nimbus Therapeutics' funding rounds
Nimbus Therapeutics has 7 venture rounds on record. This one is highlighted.
- Seed 1 Mar 2011 $1.5M
- Series A 28 Jun 2011, led by Atlas Venture, SR One and Lilly Ventures $24M
- Series B 18 Mar 2015, led by Pfizer Venture Investments and Lightstone Ventures $43M
- Growth 14 Oct 2020, led by RA Capital $60M
- Growth 13 Jul 2021, led by BVF Partners L.P. $105M
- Growth this round 12 Sep 2022, led by Bain Capital Life Sciences and SV Health Investors $125M
- Growth 6 Sep 2023, led by GV, SR One and Atlas Venture $210M
Investors
Who put money in
Bain Capital Life Sciences and SV Health Investors led the round with 8 other firms.
Lead investors
- Bain Capital Life Sciences new investor
- backs 46 venture-backed companies new investor
Also in the round
- Access Biotechnology new investor
- backs 43 venture-backed companies new investor
- BVF Partners L.P. new investor
- backs 25 venture-backed companies new investor
- Pfizer Ventures new investor
- backs 109 venture-backed companies new investor
- backs 22 venture-backed companies new investor
- Breakthrough Energy backs 113 venture-backed companies
Individual investors: Bill Gates. Joined the board: Gorjan Hrustanovic (BVF Partners, L.P.).
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
23 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $70M, and this round was 1.8 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 8 Sep 2022 | $33M | not disclosed | ARCH Venture Partners |
| Pharmaceutical Products | 7 Sep 2022 | $30M | not disclosed | Alpha Wave Global |
| Pharmaceutical Products | 20 Oct 2022 | $400M | not disclosed | Webster Equity Partners and Gurnet Point Capital |
| Pharmaceutical Products | 20 Oct 2022 | $100M | not disclosed | not named |
| Pharmaceutical Products | 4 Aug 2022 | $70M | not disclosed | Forbion and Sofinnova Partners |
| Pharmaceutical Products | 25 Oct 2022 | $25M | not disclosed | Altria Ventures |
| Pharmaceutical Products | 24 Oct 2022 | undisclosed | not disclosed | not named |
| Pharmaceutical Products | 15 Dec 2022 | $17M | not disclosed | Global Impact Fund |
Sources
Where this comes from
Reported by 3 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Nimbus Therapeutics raise in its Growth round?
Nimbus Therapeutics raised $125M in its Growth round, announced in Sep 2022.
Who led Nimbus Therapeutics' Growth round?
Bain Capital Life Sciences and SV Health Investors led it, with Access Biotechnology, Atlas Venture, BVF Partners L.P., Lightstone Ventures and Pfizer Ventures and 3 more.
What was Nimbus Therapeutics' valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
23 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $70M, and this round was 1.8 times the median.
Did Nimbus Therapeutics raise again after this round?
Yes: a Growth round in Sep 2023 of $210M.